1.58
price down icon16.49%   -0.30
 
loading
Schlusskurs vom Vortag:
$1.88
Offen:
$1.63
24-Stunden-Volumen:
2.70M
Relative Volume:
0.43
Marktkapitalisierung:
$8.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+61.92%
1M Leistung:
+118.06%
6M Leistung:
-99.56%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$1.49
$1.71
1-Wochen-Bereich:
Value
$0.85
$1.89
52-Wochen-Spanne:
Value
$0.55
$1,200.00

Polyrizon Ltd Stock (PLRZ) Company Profile

Name
Firmenname
Polyrizon Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
PLRZ's Discussions on Twitter

Vergleichen Sie PLRZ mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PLRZ
Polyrizon Ltd
1.56 7.73M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.42 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
570.29 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.27 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
582.48 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.70 31.99B 3.81B -644.79M -669.77M -6.24

Polyrizon Ltd Aktie (PLRZ) Neueste Nachrichten

pulisher
Jul 23, 2025

Is Polyrizon Ltd. a good long term investmentBreakthrough financial growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Polyrizon Ltd. Stock Analysis and ForecastExceptional growth trajectory - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Polyrizon Stock Soars 37.93% on Nasal Allergy Breakthrough - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Why Did Polyrizon Stock Soar 26.21%? - AInvest

Jul 23, 2025
pulisher
Jul 22, 2025

Polyrizon Skyrockets 66% Intraday—Can This Nasal Allergy Breakthrough Reshape Biotech? - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Polyrizon Skyrockets 61.93% Intraday, Is This the Dawn of a Biotech Breakthrough? - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Polyrizon stock soars after promising nasal allergy blocker test results - Investing.com

Jul 22, 2025
pulisher
Jul 22, 2025

Polyrizon Ltd. Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study - MarketScreener

Jul 22, 2025
pulisher
Jul 22, 2025

Polyrizon Achieves Breakthrough in Allergy Blocker Study - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Polyrizon’s nasal allergy blocker shows promising deposition results - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

Polyrizon's Nasal Barrier: A Disruptive Leap in Allergy Therapeutics? - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study - The Manila Times

Jul 22, 2025
pulisher
Jul 22, 2025

Breakthrough: New Allergy Blocker Shows 60% Success Rate in Nasal Delivery StudyMajor Step for $210M Market - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Polyrizon Ltd. stock priceDynamic investment growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Polyrizon Ltd. stockDynamic capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Polyrizon retains Nasdaq listing following hearings panel - MSN

Jul 22, 2025
pulisher
Jul 18, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Jul 18, 2025
pulisher
Jul 17, 2025

Best Biotech Stocks To Research – July 15th - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

Polyrizon Plunges 11.06% Amid Market Challenges - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Polyrizon Stock Slides After Hours After 52% Surge On Tuesday: Why It Moved - Benzinga

Jul 16, 2025
pulisher
Jul 15, 2025

Polyrizon Retains Nasdaq Listing Following Hearings Panel - 富途牛牛

Jul 15, 2025
pulisher
Jul 15, 2025

Why Polyrizon Ltd. stock attracts strong analyst attentionFree Access to Stock Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Polyrizon Ltd. stock performs during market volatilitySmart Trading With Safety Margin - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Polyrizon Ltd. stock price move sharplyFree High-Accuracy Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Polyrizon Ignites 65% Surge—What’s Driving the Unstoppable Rally? - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Polyrizon secures continued Nasdaq listing after panel hearing By Investing.com - Investing.com Canada

Jul 15, 2025
pulisher
Jul 15, 2025

Polyrizon secures continued Nasdaq listing after panel hearing - Investing.com

Jul 15, 2025
pulisher
Jul 15, 2025

Polyrizon Ltd. Secures Continued Nasdaq Listing Following Compliance Plan Implementation - Nasdaq

Jul 15, 2025
pulisher
Jul 15, 2025

Polyrizon Wins Crucial Nasdaq Appeal: Inside the $15.7M Biotech's Path to Compliance - Stock Titan

Jul 15, 2025
pulisher
Jul 06, 2025

Polyrizon, Pheton, AirSculpt: Top 3 Healthcare Stocks With Soaring Weekly Retail Interest - MSN

Jul 06, 2025
pulisher
Jul 01, 2025

Polyrizon Ltd. Announces Board Changes and Confirms Independent Directors - The Globe and Mail

Jul 01, 2025
pulisher
Jun 30, 2025

Polyrizon director Omer Srugo resigns; board affirms independent members - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Polyrizon director Omer Srugo resigns; board affirms independent members By Investing.com - Investing.com UK

Jun 30, 2025
pulisher
Jun 16, 2025

Polyrizon Ltd Inc. (PLRZ) Price Performance: How to Use Technical Analysis to Make Trading Decisions - investchronicle.com

Jun 16, 2025
pulisher
Jun 13, 2025

Polyrizon Plunges 8.5% Amid Reverse Split, Promising Drug Delivery Results - AInvest

Jun 13, 2025
pulisher
Jun 12, 2025

Polyrizon’s nasal drug delivery system shows promising results By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Polyrizon’s nasal drug delivery system shows promising results - Investing.com Australia

Jun 12, 2025
pulisher
Jun 12, 2025

Polyrizon Announces Promising Preclinical Results for CNS Therapeutics - TipRanks

Jun 12, 2025

Finanzdaten der Polyrizon Ltd-Aktie (PLRZ)

Es liegen keine Finanzdaten für Polyrizon Ltd (PLRZ) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.52
price up icon 2.89%
$36.33
price up icon 0.84%
$102.86
price down icon 0.44%
$27.62
price down icon 1.59%
$114.09
price down icon 0.58%
biotechnology ONC
$294.51
price down icon 0.08%
Kapitalisierung:     |  Volumen (24h):